-
Something wrong with this record ?
Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression
T. Hrncir, E. Trckova, L. Hrncirova
Language English Country Switzerland
Document type Journal Article
Grant support
20-09732S
Czech Science Foundation
22-12533S
Czech Science Foundation
NLK
Free Medical Journals
from 2009
PubMed Central
from 2009
Europe PubMed Central
from 2009
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Open Access Digital Library
from 2009-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2009
PubMed
39519554
DOI
10.3390/nu16213722
Knihovny.cz E-resources
- MeSH
- Gene Expression drug effects MeSH
- Fructose * adverse effects MeSH
- Liver * metabolism drug effects MeSH
- Sorbic Acid pharmacology MeSH
- Disease Models, Animal MeSH
- Mice, Inbred C57BL MeSH
- Mice MeSH
- Food Preservatives * pharmacology adverse effects MeSH
- Gastrointestinal Microbiome * drug effects MeSH
- Drug Synergism MeSH
- Fatty Liver MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of MASLD. Methods: We utilized a human microbiota-associated mouse model, administering 10% fructose with or without preservatives for 11 weeks. Liver histology, hepatic gene expression (microarray analysis), biochemical markers, cytokine profiles, intestinal permeability, and gut microbiome composition (16S rRNA and Internal Transcribed Spacer (ITS) sequencing) were evaluated. Results: Fructose and potassium sorbate synergistically induced liver pathology characterized by increased steatosis, inflammation and fibrosis. These histological changes were associated with elevated liver function markers and altered lipid profiles. The treatments also induced significant changes in both the bacterial and fungal communities and disrupted intestinal barrier function, leading to increased pro-inflammatory responses in the mesenteric lymph nodes. Liver gene expression analysis revealed a wide range of transcriptional changes induced by fructose and modulated by the preservative. Key genes involved in lipid metabolism, oxidative stress, and inflammatory responses were affected. Conclusions: Our findings highlight the complex interactions between dietary components, gut microbiota, and host metabolism in the development of MASLD. The study identifies potential risks associated with the combined consumption of fructose and preservatives, particularly potassium sorbate. Our data reveal new mechanisms that are involved in the development of MASLD and open up a new avenue for the prevention and treatment of MASLD through dietary interventions and the modulation of the microbiome.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003761
- 003
- CZ-PrNML
- 005
- 20250206104701.0
- 007
- ta
- 008
- 250121s2024 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/nu16213722 $2 doi
- 035 __
- $a (PubMed)39519554
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hrncir, Tomas $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic $1 https://orcid.org/0000000160732412
- 245 10
- $a Synergistic Effects of Fructose and Food Preservatives on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): From Gut Microbiome Alterations to Hepatic Gene Expression / $c T. Hrncir, E. Trckova, L. Hrncirova
- 520 9_
- $a Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health problem closely linked to dietary habits, particularly high fructose consumption. This study investigates the combined effects of fructose and common food preservatives (sodium benzoate, sodium nitrite, and potassium sorbate) on the development and progression of MASLD. Methods: We utilized a human microbiota-associated mouse model, administering 10% fructose with or without preservatives for 11 weeks. Liver histology, hepatic gene expression (microarray analysis), biochemical markers, cytokine profiles, intestinal permeability, and gut microbiome composition (16S rRNA and Internal Transcribed Spacer (ITS) sequencing) were evaluated. Results: Fructose and potassium sorbate synergistically induced liver pathology characterized by increased steatosis, inflammation and fibrosis. These histological changes were associated with elevated liver function markers and altered lipid profiles. The treatments also induced significant changes in both the bacterial and fungal communities and disrupted intestinal barrier function, leading to increased pro-inflammatory responses in the mesenteric lymph nodes. Liver gene expression analysis revealed a wide range of transcriptional changes induced by fructose and modulated by the preservative. Key genes involved in lipid metabolism, oxidative stress, and inflammatory responses were affected. Conclusions: Our findings highlight the complex interactions between dietary components, gut microbiota, and host metabolism in the development of MASLD. The study identifies potential risks associated with the combined consumption of fructose and preservatives, particularly potassium sorbate. Our data reveal new mechanisms that are involved in the development of MASLD and open up a new avenue for the prevention and treatment of MASLD through dietary interventions and the modulation of the microbiome.
- 650 12
- $a fruktosa $x škodlivé účinky $7 D005632
- 650 12
- $a střevní mikroflóra $x účinky léků $7 D000069196
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a játra $x metabolismus $x účinky léků $7 D008099
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a potravinářské konzervační látky $x farmakologie $x škodlivé účinky $7 D005520
- 650 _2
- $a kyselina sorbová $x farmakologie $7 D013011
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a ztučnělá játra $7 D005234
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a exprese genu $x účinky léků $7 D015870
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Trckova, Eva $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
- 700 1_
- $a Hrncirova, Lucia $u Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, 549 22 Novy Hradek, Czech Republic
- 773 0_
- $w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 16, č. 21 (2024)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39519554 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104657 $b ABA008
- 999 __
- $a ok $b bmc $g 2263504 $s 1239768
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 16 $c 21 $e 20241030 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
- GRA __
- $a 20-09732S $p Czech Science Foundation
- GRA __
- $a 22-12533S $p Czech Science Foundation
- LZP __
- $a Pubmed-20250121